Joshua N Gustine

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 8

Top Topics

Oral Anticoagulants

Replacement Therapy

Top Venues

American journal of hematology

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Joshua N Gustine, Andrew Staron, Raphael E Szalat, Lisa M Mendelson, Tracy Joshi, Frederick L Ruberg, Omar Siddiqi, Deepa M Gopal, Camille Vanessa Edwards, Andrea Havasi, Michelle C Kaku, K H Vincent Lau, John L Berk, John Mark Sloan, Vaishali Sanchorawala
Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal study. American journal of hematology 97 (9) (2022)
Jorge J Castillo, Shayna R Sarosiek, Joshua N Gustine, Catherine A Flynn, Carly R Leventoff, Timothy P White, Kirsten Meid, Maria L Guerrera, Amanda Kofides, Xia Liu, Manit Munshi, Nicholas Tsakmaklis, Zachary R Hunter, Christopher J Patterson, Andrew R Branagan, Steven P Treon
Response and survival predictors in a cohort of 319 patients with Waldenström macroglobulinemia treated with ibrutinib monotherapy. Blood advances 6 (3) (2022)
Jorge J Castillo, Kirsten Meid, Joshua N Gustine, Carly Leventoff, Timothy White, Catherine A Flynn, Shayna R Sarosiek, Maria G Demos, Maria L Guerrera, Amanda Kofides, Xia Liu, Manit Munshi, Nicholas Tsakmaklis, Lian Xu, Guang Yang, Andrew R Branagan, Elizabeth O'Donnell, Noopur Raje, Andrew J Yee, Christopher J Patterson, Zachary R Hunter, Steven P Treon
Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia. Leukemia (2021)
Joshua N Gustine, Lian Xu, Guang Yang, Xia Liu, Amanda Kofides, Nicholas Tsakmaklis, Manit Munshi, Maria Demos, Maria L Guerrera, Kirsten Meid, Christopher J Patterson, Shayna Sarosiek, Andrew R Branagan, Zachary R Hunter, Jorge J Castillo, Steven P Treon
Bone marrow involvement and subclonal diversity impairs detection of mutated CXCR4 by diagnostic next-generation sequencing in Waldenström macroglobulinaemia. British journal of haematology 194 (4) (2021)
Maria G Demos, Zachary R Hunter, Lian Xu, Nicholas Tsakmaklis, Amanda Kofides, Manit Munshi, Xia Liu, Maria Luisa Guerrera, Carly R Leventoff, Timothy P White, Catherine A Flynn, Kirsten Meid, Christopher J Patterson, Guang Yang, Andrew R Branagan, Shayna Sarosiek, Jorge J Castillo, Steven P Treon, Joshua N Gustine
Cell-free DNA analysis for detection of MYD88L265P and CXCR4S338X mutations in Waldenström macroglobulinemia. American journal of hematology 96 (7) (2021)
Jorge J Castillo, Gilad Itchaki, Joshua N Gustine, Kirsten Meid, Catherine A Flynn, Maria G Demos, Maria L Guerrera, Cristina Jimenez, Amanda Kofides, Xia Liu, Manit Munshi, Nicholas Tsakmaklis, Christopher J Patterson, Lian Xu, Guang Yang, Zachary R Hunter, Steven P Treon
A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenström macroglobulinemia. Leukemia & lymphoma 61 (6) (2020)
Jorge J Castillo, Joshua N Gustine, Kirsten Meid, Catherine A Flynn, Maria G Demos, Maria L Guerrera, Cristina Jimenez, Amanda Kofides, Xia Liu, Manit Munshi, Nicholas Tsakmaklis, Christopher J Patterson, Lian Xu, Guang Yang, Zachary R Hunter, Steven P Treon
CXCR4 mutational status does not impact outcomes in patients with Waldenström macroglobulinemia treated with proteasome inhibitors. American journal of hematology 95 (4) (2020)
Joshua N Gustine, Lian Xu, Nicholas Tsakmaklis, Maria G Demos, Amanda Kofides, Jiaji G Chen, Xia Liu, Manit Munshi, Maria Luisa Guerrera, Gloria G Chan, Christopher J Patterson, Andrew Keezer, Kirsten Meid, Toni Dubeau, Guang Yang, Zachary R Hunter, Steven P Treon, Jorge J Castillo
CXCR4 S338X clonality is an important determinant of ibrutinib outcomes in patients with Waldenström macroglobulinemia. Blood advances 3 (19) (2020)